相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2020)
A bispecific antibody strategy to target multiple type 2 cytokines in asthma
Marie Godar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
Richard J. Russell et al.
LANCET RESPIRATORY MEDICINE (2018)
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
Reynold A. Panettieri et al.
LANCET RESPIRATORY MEDICINE (2018)
Anti-interleukin 13 for asthma: stick or twist?
Brian Lipworth et al.
LANCET RESPIRATORY MEDICINE (2018)
Commonality of the IL-4/IL-13 pathway in atopic diseases
Namita A. Gandhi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders
Erik Wambre et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Memory-type ST2+CD4+T cells participate in the steroid-resistant pathology of eosinophilic pneumonia
Naoko Mato et al.
SCIENTIFIC REPORTS (2017)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Novel Biologicals for the Treatment of Allergic Diseases and Asthma
Hern-Tze Tina Tan et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2016)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial
Claus Bachert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Sally Wenzel et al.
LANCET (2016)
Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
J. Mark FitzGerald et al.
LANCET (2016)
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
Diamant Thaci et al.
LANCET (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
Nicola A. Hanania et al.
LANCET RESPIRATORY MEDICINE (2016)
IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk
D. Kaur et al.
ALLERGY (2015)
Strategies targeting the IL-4/IL-13 axes in disease
Richard D. May et al.
CYTOKINE (2015)
IL-4 and IL-13 signaling in allergic airway disease
Naina Gour et al.
CYTOKINE (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
Arash Grakoui et al.
JOURNAL OF IMMUNOLOGY (2015)
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Jennifer D. Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Lung niches for the generation and maintenance of tissue-resident memory T cells
D. L. Turner et al.
MUCOSAL IMMUNOLOGY (2014)
Intravascular staining for discrimination of vascular and tissue leukocytes
Kristin G. Anderson et al.
NATURE PROTOCOLS (2014)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
Lynn E. Macdonald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
Andrew J. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Pathogenic memory type Th2 cells in allergic inflammation
Yusuke Endo et al.
TRENDS IN IMMUNOLOGY (2014)
Role of Interleukin-13 in Asthma
Jonathan Corren
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Fluorescent In Vivo Detection Reveals that IgE+ B Cells Are Restrained by an Intrinsic Cell Fate Predisposition
Zhiyong Yang et al.
IMMUNITY (2012)
Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production
Dawn C. Newcomb et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Murine lung eosinophil activation and chemokine production in allergic airway inflammation
C. Edward Rose et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
IgE, mast cells, basophils, and eosinophils
Kelly D. Stone et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Cytokine-secreting follicular T cells shape the antibody repertoire
R. Lee Reinhardt et al.
NATURE IMMUNOLOGY (2009)
Immune homeostasis in the respiratory tract and its impact on heterologous infection
Erika Wissinger et al.
SEMINARS IN IMMUNOLOGY (2009)
Generation of Th1 and Th2 chemokines by human eosinophils:: Evidence for a critical role of TNF-α
Lin Ying Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Clinical relevance of airway remodelling in airway diseases
A. L. James et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Eosinophil trafficking in allergy and asthma
Helene F. Rosenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Mast cells express IL-13αR1: IL-13 promotes human lung mast cell proliferation and FcεRI expression
D. Kaur et al.
ALLERGY (2006)
IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos
A Lorentz et al.
JOURNAL OF IMMUNOLOGY (2005)
The re-emergence pivotal cell in of the mast cell as a asthma pathogenesis
CE Brightling et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2005)
Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling
JR Johnson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes
EJ Sundberg et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice
T Biedermann et al.
NATURE IMMUNOLOGY (2001)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells
H Hochrein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
IL-4 is a mediator of IL-12p70 induction by human Th2 cells: Reversal of polarized Th2 phenotype by dendritic cells
P Kalinski et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
